0.26 USD
↘ 0.01 (3.24%)AT CLOSE (11:59 AM EDT)
AEON Biopharma, Inc.
AEONAMEX • USD
0.26
↗ 0.00 (1.17%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
0.26
↗ 0.00 (1.17%)
Market: CLOSED
AEON is currently priced at $0.26. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (355.6%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Sep 16, 2026.
Open?$0.27
High?$0.28
Low?$0.25
Prev. Close?$0.27
Volume?1.5M
Avg. Volume?11.0M
VWAP?$0.26
Rel. Volume?0.14x
Bid / Ask
Bid?$0.26 × 3.0K
Ask?$0.26 × 500
Spread?$0.01
Midpoint?$0.26
Valuation & Ratios
Market Cap?13.5M
Shares Out?49.9M
Float?11.4M
Float %?22.8%
P/E Ratio?N/A
P/B Ratio?-0.88
EPS?-$1.10
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
Employees
8
Market Cap
13.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-07-24
Address
130 VANTIS DRIVE
ALISO VIEJO, CA 92656
Phone: (949) 354-6499
ALISO VIEJO, CA 92656
Phone: (949) 354-6499
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?34
Piotroski F-Score?0/9Weak
Altman Z-Score?-125.99Distress
Confidence?49%Low
Short InterestHigh
Short % of Float?15.90%High
Short Interest?1.8M
Days to Cover?1.0
Free Float11.4M
Avg Daily Volume7.4M
Settlement Date2026-08-31
Financial Health
Current Ratio?0.54Weak
Quick Ratio?0.54Weak
Cash Ratio?0.47Low
Debt/Equity?-0.17Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-0.88CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.6CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?355.6%STRONG▾
Peers50
S&P97
ROA?-924.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-13642000
Enterprise Value?$12.7M
Fundamentals ratios updated end of day